Healthcare -
Biotechnology - NASDAQ - US
$ 31.47
-6.08 %
$ 2.89 B
Market Cap
-32.68
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Legend Biotech Corporation
| Net Income | -158 M |
| Depreciation & Amortization | 23.4 M |
| Capital Expenditures | -14.1 M |
| Stock-Based Compensation | 68.9 M |
| Change in Working Capital | 20 M |
| Others | -169 M |
| Free Cash Flow | -158 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||
| Net Income | (158.1) | (518.3) | (445.7) | (386.2) | (307.6) | (130.4) | (1.6) | 9.4 |
| Depreciation & Amortization | 23.4 | 20.5 | 18.4 | 13.9 | 9.9 | 5.3 | 1.7 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0 | (174.9) | 9.2 | (7.4) | (5.7) | 0 |
| Stock Based Compensation | 68.9 | 47.7 | 34.3 | 20.2 | 4.8 | 1.3 | 0.7 | 0 |
| Other Operating Activities | (98.2) | 128.2 | 6.6 | 187.7 | 84.6 | (4.4) | (6.1) | 228.9 |
| Change in Working Capital | 20.0 | (71.3) | 186.3 | 140.9 | (23.9) | 52.5 | 318.7 | (16.5) |
| Cash From Operations | (144.0) | (393.3) | (200.0) | (198.5) | (223.0) | (83.1) | 307.7 | (2.4) |
| INVESTING CASH FLOW | ||||||||
| Capital Expenditures | (14.1) | (22.7) | (22.3) | (47.1) | (49.8) | (39.2) | (21.0) | (0.9) |
| Other Items | (836.4) | 115.5 | (56.1) | (147.9) | 25.6 | (19.5) | (81.2) | 60 K |
| Cash From Investing Activities | (850.5) | 92.8 | (78.3) | (195.0) | (24.2) | (58.7) | (102.3) | (0.8) |
| FINANCING CASH FLOW | ||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (4.0) | (3.8) | (2.6) | (1.4) | (2.6) | (5.1) | (0.2) | 32 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.7 | 211.6 | 2.9 | 4.6 | 159.4 | 19.7 | 2.7 | 3.4 |
| Cash From Financing Activities | 5.7 | 791.5 | 378.0 | 626.7 | 618.9 | 14.7 | 2.5 | 3.3 |
| CHANGE IN CASH | ||||||||
| Net Change In Cash | (991.0) | 491.7 | 97.1 | 233.2 | 372.3 | (126.8) | 208.1 | 0.1 |
| FREE CASH FLOW | ||||||||
| Free Cash Flow | (158.1) | (416.0) | (222.3) | (245.6) | (272.8) | (122.2) | 286.7 | (3.3) |